{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:22:46Z","timestamp":1789017766117,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T00:00:00Z","timestamp":1534377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Natural Scientific Research Fund of China","award":["8150010416"],"award-info":[{"award-number":["8150010416"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00277-018-3467-6","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T11:03:44Z","timestamp":1534417424000},"page":"2381-2389","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Persistent peripheral blood EBV-DNA positive with high expression of PD-L1 and upregulation of CD4 + CD25 + T cell ratio in early stage NK\/T cell lymphoma patients may predict worse outcome"],"prefix":"10.1007","volume":"97","author":[{"given":"Peng-fei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ze","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-qi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,16]]},"reference":[{"issue":"25","key":"3467_CR1","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D, International TCLP (2008) International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol Off J Am Soc Clin Oncol 26(25):4124\u20134130","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"2","key":"3467_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12308-009-0034-z","volume":"2","author":"MS Lim","year":"2009","unstructured":"Lim MS, de Leval L, Quintanilla-Martinez L (2009) Commentary on the 2008 WHO classification of mature T- and NK-cell neoplasms. J Hematop 2(2):65\u201373","journal-title":"J Hematop"},{"issue":"2","key":"3467_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/cncr.11908","volume":"100","author":"CC Li","year":"2004","unstructured":"Li CC, Tien HF, Tang JL, Yao M, Chen YC, Su IJ, Hsu SM, Hong RL (2004) Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer\/T-cell or T-cell lymphoma. Cancer 100(2):366\u2013375","journal-title":"Cancer"},{"issue":"1","key":"3467_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","volume":"103","author":"CS Chim","year":"2004","unstructured":"Chim CS, Ma SY, Au WY, Choy C, Lie AK, Liang R, Yau CC, Kwong YL (2004) Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 103(1):216\u2013221","journal-title":"Blood"},{"issue":"1","key":"3467_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijrobp.2007.05.073","volume":"70","author":"MJ Huang","year":"2008","unstructured":"Huang MJ, Jiang Y, Liu WP, Li ZP, Li M, Zhou L, Xu Y, Yu CH, Li Q, Peng F, Liu JY, Luo F, Lu Y (2008) Early or up-front radiotherapy improved survival of localized extranodal NK\/T-cell lymphoma, nasal-type in the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 70(1):166\u2013174","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"3467_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.oraloncology.2006.11.020","volume":"44","author":"Y Guo","year":"2008","unstructured":"Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J (2008) Combined chemoradiation for the management of nasal natural killer (NK)\/T-cell lymphoma: elucidating the significance of systemic chemotherapy. Oral Oncol 44(1):23\u201330","journal-title":"Oral Oncol"},{"issue":"3","key":"3467_CR7","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s12032-014-0860-4","volume":"31","author":"L Wang","year":"2014","unstructured":"Wang L, Wang WD, Xia ZJ, Zhang YJ, Xiang J, Lu Y (2014) Combination of gemcitabine, L-asparaginase, and oxaliplatin (GELOX) is superior to EPOCH or CHOP in the treatment of patients with stage IE\/IIE extranodal natural killer\/T cell lymphoma: a retrospective study in a cohort of 227 patients with long-term follow-up. Med Oncol 31(3):860","journal-title":"Med Oncol"},{"issue":"2","key":"3467_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/cncr.27752","volume":"119","author":"L Wang","year":"2013","unstructured":"Wang L, Wang ZH, Chen XQ, Li YJ, Wang KF, Xia YF, Xia ZJ (2013) First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE\/IIE extranodal natural killer\/T-cell lymphoma. Cancer 119(2):348\u2013355","journal-title":"Cancer"},{"issue":"9","key":"3467_CR9","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00277-015-2395-y","volume":"94","author":"XW Bi","year":"2015","unstructured":"Bi XW, Xia Y, Zhang WW, Sun P, Liu PP, Wang Y, Huang JJ, Jiang WQ, Li ZM (2015) Radiotherapy and PGEMOX\/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK\/T-cell lymphoma. Ann Hematol 94(9):1525\u20131533","journal-title":"Ann Hematol"},{"issue":"1","key":"3467_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/annonc\/mdq314","volume":"22","author":"JJ Huang","year":"2011","unstructured":"Huang JJ, Jiang WQ, Lin TY, Huang Y, Xu RH, Huang HQ, Li ZM (2011) Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer\/T-cell lymphoma, nasal type. Annals of Oncology: Official Journal of the European Society for Medical Oncology\/ESMO 22(1):149\u2013155","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology\/ESMO"},{"issue":"2","key":"3467_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/bjc.2012.566","volume":"108","author":"Q Cai","year":"2013","unstructured":"Cai Q, Luo X, Liang Y, Rao H, Fang X, Jiang W, Lin T, Lin T, Huang H (2013) Fasting blood glucose is a novel prognostic indicator for extranodal natural killer\/T-cell lymphoma, nasal type. Br J Cancer 108(2):380\u2013386","journal-title":"Br J Cancer"},{"issue":"5","key":"3467_CR12","doi-asserted-by":"publisher","first-page":"e64158","DOI":"10.1371\/journal.pone.0064158","volume":"8","author":"YJ Li","year":"2013","unstructured":"Li YJ, Li ZM, Xia Y, Huang JJ, Huang HQ, Xia ZJ, Lin TY, Li S, Cai XY, Wu-Xiao ZJ, Jiang WQ (2013) Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer\/T-cell lymphoma, nasal type. PLoS One 8(5):e64158","journal-title":"PLoS One"},{"issue":"33","key":"3467_CR13","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","volume":"29","author":"M Yamaguchi","year":"2011","unstructured":"Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, Suzumiya J, Kodama T, Kimura H, Hyo R, Nakamura S, Oshimi K, Suzuki R (2011) Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-cell tumor study group study. J Clin Oncol Off J Am Soc Clin Oncol 29(33):4410\u20134416","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"3467_CR14","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","volume":"24","author":"J Lee","year":"2006","unstructured":"Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, Lee DH, Huh J, Oh SY, Kwon HC, Kim HJ, Lee SI, Kim JH, Park J, Oh SJ, Kim K, Jung C, Park K, Kim WS (2006) Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol Off J Am Soc Clin Oncol 24(4):612\u2013618","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"3","key":"3467_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","volume":"17","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Yoon DH, Jaccard A, Chng WJ, Lim ST, Hong H, Park Y, Chang KM, Maeda Y, Ishida F, Shin DY, Kim JS, Jeong SH, Yang DH, Jo JC, Lee GW, Choi CW, Lee WS, Chen TY, Kim K, Jung SH, Murayama T, Oki Y, Advani R, d\u2019Amore F, Schmitz N, Suh C, Suzuki R, Kwong YL, Lin TY, Kim WS (2016) A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. The Lancet Oncology 17(3):389\u2013400","journal-title":"The Lancet Oncology"},{"issue":"3","key":"3467_CR16","first-page":"83","volume":"102","author":"E Sabattini","year":"2010","unstructured":"Sabattini E, Bacci F, Sagramoso C, Pileri SA (2010) WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 102(3):83\u201387","journal-title":"Pathologica"},{"issue":"5","key":"3467_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.biologicals.2016.04.010","volume":"44","author":"JF Fryer","year":"2016","unstructured":"Fryer JF, Heath AB, Wilkinson DE, Minor PD, Collaborative Study Group (2016) A collaborative study to establish the 1st WHO international standard for Epstein-Barr virus for nucleic acid amplification techniques. Biologicals: Journal of the International Association of Biological Standardization 44(5):423\u2013433","journal-title":"Biologicals: Journal of the International Association of Biological Standardization"},{"issue":"4","key":"3467_CR18","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A et al (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI sponsored international working group. J Clin Oncol Off J Am Soc Clin Oncol 17(4):1244","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"9","key":"3467_CR19","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s00277-015-2403-2","volume":"94","author":"S Paydas","year":"2015","unstructured":"Paydas S, Bagir E, Seydaoglu G, Ercolak V, Ergin M (2015) Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma. Ann Hematol 94(9):1545\u20131552","journal-title":"Ann Hematol"},{"issue":"10","key":"3467_CR20","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood-2012-06-435024","volume":"120","author":"ZY Wang","year":"2012","unstructured":"Wang ZY, Liu QF, Wang H, Jin J, Wang WH, Wang SL, Song YW, Liu YP, Fang H, Ren H, Wu RY, Chen B, Zhang XM, Lu NN, Zhou LQ, Li YX (2012) Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK\/T-cell lymphoma patients receiving primary radiotherapy. Blood 120(10):2003\u20132010","journal-title":"Blood"},{"issue":"4","key":"3467_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/leu.2013.212","volume":"28","author":"YL Kwong","year":"2014","unstructured":"Kwong YL, Pang AW, Leung AY, Chim CS, Tse E (2014) Quantification of circulating Epstein-Barr virus DNA in NK\/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance. Leukemia 28(4):865\u2013870","journal-title":"Leukemia"},{"issue":"30","key":"3467_CR22","doi-asserted-by":"crossref","first-page":"30317","DOI":"10.18632\/oncotarget.4505","volume":"6","author":"L Wang","year":"2015","unstructured":"Wang L, Wang H, Wang JH, Xia ZJ, Lu Y, Huang HQ, Jiang WQ, Zhang YJ (2015) Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK\/T cell lymphoma in the era of asparaginase. Oncotarget 6(30):30317\u201330326","journal-title":"Oncotarget"},{"issue":"2","key":"3467_CR23","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1016\/S2352-3026(15)00002-2","volume":"2","author":"SJ Kim","year":"2015","unstructured":"Kim SJ, Choi JY, Hyun SH, Ki CS, Oh D, Ahn YC, Ko YH, Choi S, Jung SH, Khong PL, Tang T, Yan X, Lim ST, Kwong YL, Kim WS, Asia Lymphoma Study Group (2015) Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer\/T-cell lymphoma, nasal type: a multicentre, retrospective analysis. The Lancet Haematology 2(2):e66\u2013e74","journal-title":"The Lancet Haematology"},{"issue":"1","key":"3467_CR24","first-page":"29","volume":"8","author":"KI Lei","year":"2002","unstructured":"Lei KI, Chan LY, Chan WY, Johnson PJ, Lo YM (2002) Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer\/T-cell lymphoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(1):29\u201334","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"issue":"1","key":"3467_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","volume":"104","author":"WY Au","year":"2004","unstructured":"Au WY, Pang A, Choy C, Chim CS, Kwong YL (2004) Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 104(1):243\u2013249","journal-title":"Blood"},{"issue":"5","key":"3467_CR26","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/jmv.20853","volume":"79","author":"H Ishii","year":"2007","unstructured":"Ishii H, Ogino T, Berger C, Kochli-Schmitz N, Nagato T, Takahara M, Nadal D, Harabuchi Y (2007) Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for nasal NK\/T-cell lymphoma. J Med Virol 79(5):562\u2013572","journal-title":"J Med Virol"},{"issue":"5","key":"3467_CR27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/10428190902803669","volume":"50","author":"HS Kim","year":"2009","unstructured":"Kim HS, Kim KH, Kim KH, Chang MH, Ji SH, Lim DH, Kim K, Kim SJ, Ko Y, Ki CS, Jo SJ, Lee JW, Kim WS (2009) Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer\/T-cell lymphoma. Leukemia & Lymphoma 50(5):757\u2013763","journal-title":"Leukemia & Lymphoma"},{"issue":"23","key":"3467_CR28","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1182\/blood-2011-05-354142","volume":"118","author":"R Suzuki","year":"2011","unstructured":"Suzuki R, Yamaguchi M, Izutsu K, Yamamoto G, Takada K, Harabuchi Y, Isobe Y, Gomyo H, Koike T, Okamoto M, Hyo R, Suzumiya J, Nakamura S, Kawa K, Oshimi K, the NK-cell Tumor Study Group (2011) Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK\/T-cell lymphoma, nasal type. Blood 118(23):6018\u20136022","journal-title":"Blood"},{"issue":"15","key":"3467_CR29","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1158\/1078-0432.CCR-12-1064","volume":"18","author":"Y Ito","year":"2012","unstructured":"Ito Y, Kimura H, Maeda Y, Hashimoto C, Ishida F, Izutsu K, Fukushima N, Isobe Y, Takizawa J, Hasegawa Y, Kobayashi H, Okamura S, Kobayashi H, Yamaguchi M, Suzumiya J, Hyo R, Nakamura S, Kawa K, Oshimi K, Suzuki R (2012) Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK\/T-cell lymphoma, nasal type. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 18(15):4183\u20134190","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"key":"3467_CR30","doi-asserted-by":"publisher","first-page":"12168","DOI":"10.1038\/srep12168","volume":"5","author":"TX Lu","year":"2015","unstructured":"Lu TX, Liang JH, Miao Y, Fan L, Wang L, Qu XY, Cao L, Gong QX, Wang Z, Zhang ZH, Xu W, Li JY (2015) Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age. Sci Rep 5:12168","journal-title":"Sci Rep"},{"issue":"2","key":"3467_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/cei.12682","volume":"182","author":"D Cardenas","year":"2015","unstructured":"Cardenas D, Velez G, Orfao A, Herrera MV, Solano J, Olaya M, Uribe AM, Saavedra C, Duarte M, Rodriguez M et al (2015) Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired. Clin Exp Immunol 182(2):173\u2013183","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"3467_CR32","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3109\/10428194.2015.1087522","volume":"57","author":"Q Cui","year":"2016","unstructured":"Cui Q, Gandhi MK (2016) Whole blood EBV-DNA: a surrogate for immune dysfunction in aggressive lymphoma? Leukemia & Lymphoma 57(3):507\u2013508","journal-title":"Leukemia & Lymphoma"},{"issue":"17","key":"3467_CR33","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","volume":"129","author":"YL Kwong","year":"2017","unstructured":"Kwong YL, Chan TSY, Tan D, Kim SJ, Poon LM, Mow B, Khong PL, Loong F, Au-Yeung R, Iqbal J, Phipps C, Tse E (2017) PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase. Blood 129(17):2437\u20132442","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3467-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3467-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3467-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T21:22:30Z","timestamp":1604784150000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3467-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,16]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3467"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3467-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,16]]},"assertion":[{"value":"25 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"As a retrospective analysis of prognostic factors, no approval from the Regional Committee for Medical and Health Research Ethics was necessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained informed consent for collecting and publishing medical information from all patients at their first visit.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}